Organization | University of Rostock

University of Rostock Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Rostock Germany (1419)

Organization Overview

First Clinical Trial

1993

NCT00002532

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Dep. of Anesthesia and Intensive Care Medicine, University of Rostock, Germany | Dept. fof Pneumology, University Clinic Rostock, Ernst-Heydemann-Str. 6, 18057 Rostock, Germany | HELIOS Klinik Hagen Ambrock | HELIOS Klinikum Emil von Behring | Helios Research Center | Klinik und Poliklinik fuer Innere Medizin - Universitaet Rostock | Klinische Forschung Schwerin GmbH | Max Dieterich | Medical University Rostock | Universitätsklinik Rostock - Hospital | Universitätsmedizin Rostock | Universitätsmedizin Rostock Versorgungsstrukturen GmbH | Universitiy of Rostock | University Childrens Hospital, Rostock | University Hospital of Rostock, Germany | University Hospital Rostock | University Hospital Rostock, Clinic for Radiotherapy | University Medical Center Rostock | University Medicine Rostock | University of Rostock | University of Rostock, Department of Obstetrics and Gynecology | University of Rostock, Eye Department

Active Ingredients

Drugs in Phase 4 Trials (8)

benralizumab (fasenra) (1 trial)

hydroxyethyl starch (voluven) (1 trial)

midazolam (versed) (2 trials)

oxycodone (oxycontin) (1 trial)

pazopanib (votrient) (1 trial)

piritramide (1 trial)

prilocaine (citanest) (3 trials)

sodium chloride (2 trials)

Drugs in Phase 3 Trials (8)

allogeneic adipose derived mesenchymal stem cell (1 trial)

autologous cd133+ stem cells (1 trial)

bupropion (wellbutrin) (1 trial)

fluorouracil (efudex) (1 trial)

gemcitabine (gemzar) (1 trial)

house dust mite allergen (1 trial)

irinotecan (Camptosar) (1 trial)

leucovorin (2 trials)

Drugs in Phase 2 Trials (20)

asparaginase (elspar) (1 trial)

betamethasone (celestone) (1 trial)

buspirone (buspar) (1 trial)

calcipotriene (dovonex) (1 trial)

cytarabine (cytosar-u) (1 trial)

daunorubicin (cerubidine) (1 trial)

etoposide (vepesid) (1 trial)

idarubicin (idamycin) (1 trial)

ifosfamide (ifex) (1 trial)

Measles, Mumps and Rubella Vaccine, Live (Priorix) (1 trial)

mv-chik (1 trial)

naltrexone (revia) (1 trial)

oxygen (1 trial)

prednisone (meticorten) (1 trial)

sargramostim (leukine) (1 trial)

Tanimilast (1 trial)

treosulfan (2 trials)

vincristine (oncovin) (1 trial)

Drugs in Phase 1 Trials (4)

benzyldodecyldimethylammonium chloride (1 trial)

fluticasone (cutivate) (2 trials)

salmeterol (serevent) (2 trials)

somatropin (protropin) (1 trial)

Drugs in Other Trials (7)

acetylsalicylic acid (aspirin) (1 trial)

clopidogrel (plavix) (1 trial)

hymenoptera venom (1 trial)

propofol (diprivan) (1 trial)

rocuronium (zemuron) (2 trials)

ropivacaine (naropin) (3 trials)

sevoflurane (ultane) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Alzheimer Disease (Phase 3)

Asthma (Phase 4)

Chikungunya Fever (Phase 2)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 4)

Coronary Artery Disease (Phase 3)

Dementia (Phase 3)

Dyskinesias (Phase 2)

Eye Diseases (Phase 1)

Familial Hypophosphatemic Rickets (Phase 1)

Growth Disorders (Phase 1)

Infections (Phase 4)

Ischemia (Phase 3)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lung Diseases (Phase 1)

Lung Diseases, Obstructive (Phase 1)

Myocardial Ischemia (Phase 3)

Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 3)

Parkinson Disease (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Psoriasis (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 1)

Pulmonary Eosinophilia (Phase 4)

Rickets (Phase 1)

Rickets, Hypophosphatemic (Phase 1)

Sarcoma (Phase 4)

Virus Diseases (Phase 2)

Xerostomia (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 31
# of Trial APIs: 47